| 000 | 01616 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250517130825.0 | ||
| 264 | 0 | _c20180112 | |
| 008 | 201801s 0 0 eng d | ||
| 022 | _a1029-2403 | ||
| 024 | 7 |
_a10.1080/10428194.2016.1267350 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFalantes, Jose F | |
| 245 | 0 | 0 |
_aThe incorporation of comorbidities in the prognostication of patients with lower-risk myelodysplastic syndrome. _h[electronic resource] |
| 260 |
_bLeukemia & lymphoma _c08 2017 |
||
| 300 |
_a1893-1902 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 | _aBiomarkers |
| 650 | 0 | 4 |
_aBone Marrow _xpathology |
| 650 | 0 | 4 | _aCause of Death |
| 650 | 0 | 4 | _aComorbidity |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIncidence |
| 650 | 0 | 4 | _aLeukocyte Count |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMyelodysplastic Syndromes _xdiagnosis |
| 650 | 0 | 4 | _aPrevalence |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aRisk |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 | _aSymptom Assessment |
| 700 | 1 | _aMárquez-Malaver, Francisco J | |
| 700 | 1 | _aKnight, Teresa | |
| 700 | 1 | _aCalderón-Cabrera, Cristina | |
| 700 | 1 | _aMartino, María L | |
| 700 | 1 | _aGonzález, Jose | |
| 700 | 1 | _aMontero, Isabel | |
| 700 | 1 | _aEspigado, Ildefonso | |
| 700 | 1 | _aPérez-Simón, Jose A | |
| 773 | 0 |
_tLeukemia & lymphoma _gvol. 58 _gno. 8 _gp. 1893-1902 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/10428194.2016.1267350 _zAvailable from publisher's website |
| 999 |
_c26689451 _d26689451 |
||